Chloroxine
Drug profile
Also known as: chlofucid, chloroxyquinoline, clofuzid, dichlorohydroxyquinoline, dichloroquinolinol, dichloroxin, endiaron, quinolor, quixalin
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Chloroxine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1976. DrugCentral lists 10 molecular targets, including ALOX12, MMP14 and ALOX15. Recorded indications include Pityriasis simplex and Seborrheic dermatitis.
- Approval status: ofm (first approved 1976 by the FDA).
- Molecular targets: ALOX12, MMP14, ALOX15 and ALOX5 (10 listed in DrugCentral).
- Indications: Pityriasis simplex and Seborrheic dermatitis.
- Molecular formula: C9H5Cl2NO; molecular weight 214.05 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Pityriasis simplex
- Seborrheic dermatitis
Contraindications (1)
- Denuded skin
Mechanism & targets
Molecular targets (10)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Arachidonate 12-lipoxygenase, 12S-type | ALOX12 | unknown | IC50 5.72 |
| Matrix metalloproteinase-14 | MMP14 | unknown | Kd 5.62 |
| Arachidonate 15-lipoxygenase | ALOX15 | unknown | IC50 5.62 |
| Arachidonate 5-lipoxygenase | ALOX5 | unknown | IC50 5.44 |
| Replicase polyprotein 1ab | REP | unknown | Kd 5.34 |
| Beta-lactamase NDM-1 | blaNDM-1 | unknown | IC50 5.31 |
| Botulinum neurotoxin type A | botA | unknown | IC50 4.94 |
| Matrix metalloproteinase-9 | MMP9 | unknown | IC50 4.80 |
| Collagenase 3 | MMP13 | unknown | IC50 4.71 |
| Arachidonate 15-lipoxygenase, type II | ALOX15B | unknown | IC50 4.55 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1976-10-19 | FDA | — | — |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Chloroxine is on its molecule page.
| Molecular formula | C9H5Cl2NO |
|---|---|
| Molecular weight | 214.05 g/mol |
| CAS number | 773-76-2 |
| InChIKey | WDFKMLRRRCGAKS-UHFFFAOYSA-N |
| PubChem CID | 2722 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Chloroxine used for?
DrugCentral lists the following indications for Chloroxine: Pityriasis simplex and Seborrheic dermatitis.
How does Chloroxine work?
Its molecular targets in DrugCentral include ALOX12, MMP14, ALOX15 and ALOX5.
When was Chloroxine first approved?
Chloroxine was first approved by the FDA in 1976.
What is the chemical formula of Chloroxine?
Chloroxine has the molecular formula C9H5Cl2NO and a molecular weight of 214.05 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 611 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200596 — compound record and bioactivity
- PubChem CID 2722 — chemical identifiers
- DrugBank DB01243 — drug record
- FDA UNII 2I8BD50I8B — substance identity
- DailyMed: FDA labels for Chloroxine — current prescribing information (label search)
- UniProt P18054 (ALOX12) — target protein
- UniProt P50281 (MMP14) — target protein
- UniProt P16050 (ALOX15) — target protein
- UniProt P09917 (ALOX5) — target protein
- UniProt P14780 (MMP9) — target protein
- UniProt P45452 (MMP13) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.